These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus. Watala C Curr Pharm Des; 2005; 11(18):2331-65. PubMed ID: 16022671 [TBL] [Abstract][Full Text] [Related]
5. [Acetylsalicylic acid and diabetes mellitus]. Paiva S Acta Med Port; 2002; 15(3):199-202. PubMed ID: 12379997 [TBL] [Abstract][Full Text] [Related]
6. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. Colwell JA Am J Cardiovasc Drugs; 2004; 4(2):87-106. PubMed ID: 15049721 [TBL] [Abstract][Full Text] [Related]
7. Adenosinediphosphate induced platelet adhesiveness in diabetes mellitus with complications. Hellem AJ Acta Med Scand; 1971 Oct; 190(4):291-5. PubMed ID: 5124260 [No Abstract] [Full Text] [Related]
8. The platelet in diabetes: focus on prevention of ischemic events. Colwell JA; Nesto RW Diabetes Care; 2003 Jul; 26(7):2181-8. PubMed ID: 12832332 [TBL] [Abstract][Full Text] [Related]
9. Platelets and antiplatelet therapy in patients with diabetes mellitus. Arjomand H; Roukoz B; Surabhi SK; Cohen M J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635 [TBL] [Abstract][Full Text] [Related]
10. Platelets Express Activated P2Y Hu L; Chang L; Zhang Y; Zhai L; Zhang S; Qi Z; Yan H; Yan Y; Luo X; Zhang S; Wang Y; Kunapuli SP; Ye H; Ding Z Circulation; 2017 Aug; 136(9):817-833. PubMed ID: 28637879 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention. Sepúlveda C; Palomo I; Fuentes E Vascul Pharmacol; 2017 Apr; 91():10-17. PubMed ID: 28342822 [TBL] [Abstract][Full Text] [Related]
12. [Clinical aspects of drug interactions with selected antiplatelet drugs]. Kostka-Trabka E; Woroń J Pol Merkur Lekarski; 2000 Sep; 9(51):602-4. PubMed ID: 11126984 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet effect of statins is augmented in diabetic rabbits. Kocić I; Racek-Król B; Wapniarska I; Rusiecka I; Wasilewski R; Bitel M Pharmacol Rep; 2010; 62(2):410-3. PubMed ID: 20508298 [TBL] [Abstract][Full Text] [Related]
15. Potential of Anthocyanin to Prevent Cardiovascular Disease in Diabetes. Gaiz AA; Mosawy S; Colson N; Singh I Altern Ther Health Med; 2018 May; 24(3):40-47. PubMed ID: 29477135 [TBL] [Abstract][Full Text] [Related]
16. Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment. Mathewkutty S; McGuire DK Expert Rev Cardiovasc Ther; 2009 May; 7(5):541-9. PubMed ID: 19419262 [TBL] [Abstract][Full Text] [Related]
17. Platelet Hyperreactivity in Diabetes: Focus on GPVI Signaling-Are Useful Drugs Already Available? Arthur JF; Jandeleit-Dahm K; Andrews RK Diabetes; 2017 Jan; 66(1):7-13. PubMed ID: 27999100 [TBL] [Abstract][Full Text] [Related]
18. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?]. Legrand DA; Scheen AJ Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540 [TBL] [Abstract][Full Text] [Related]
19. Variability in the response to antiplatelet treatment in diabetes mellitus. Davì G; Vazzana N; Sestili S Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):48-55. PubMed ID: 22330860 [TBL] [Abstract][Full Text] [Related]
20. Pivotal role of platelets in critical illness: evidence behind clinical interventions. Collins AS Dimens Crit Care Nurs; 2004; 23(5):217-21. PubMed ID: 15722844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]